Wave Life Sciences Ltd. (WVE)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-30) · 99.1 · 99.2 | ||
| 10-K/A | FY-2025 | |||
| 10-Q | Q1-2026 | 8-K (2026-04-28) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-26) · 99.1 · 99.2 | 8-K (2026-01-12) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-07-30) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 · 99.2 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-03-04) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 · 99.2 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-03-06) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 | ||
| 10-K/A | FY-2022 | |||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | — |
|
| Unaudited Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets (P) | — |
|
| Unaudited Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Unaudited Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Unaudited Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Series A Preferred Shares and Shareholders' Equity | — |
|
| Unaudited Consolidated Statements of Series A Preferred Shares and Shareholders' Equity | — |
|
| Unaudited Consolidated Statements of Series A Preferred Shares and Shareholders' Equity (deficit) | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Unaudited Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Collaboration Agreements | ||
| Commitments and Contingencies | — |
|
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Employee Benefit Plans | — |
|
| Fair Value of Financial Instruments | — |
|
| Geographic Data | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Leases | — |
|
| Marketable Securities | — |
|
| Net Income (loss) Per Ordinary Share | — |
|
| Net Loss Per Ordinary Share | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Related Parties | — |
|
| Related Party Transactions | — |
|
| Segment Information | ||
| Share Capital | — |
|
| Share-based Compensation | ||
| Shareholders' Equity | — |
|
| Significant Accounting Policies | ||
| The Company | ||